Business
AstraZeneca COVID-19 vaccine trial volunteer ‘had neurological symptoms’ – Sydney Morning Herald
A woman in the trial in the UK had symptoms consistent with a rare but serious spinal inflammatory disorder, according to a report.
AstraZeneca said a woman in the United Kingdom had symptoms consistent with a rare but serious spinal inflammatory disorder, which led to the British drugmaker’s decision to stop its clinical study of the new coronavirus vaccine, Stat News has reported.
The participant was recovering and will likely be discharged from the hospital within a day, according to Stat News, which said on Wednesday the new disclosures by Astra Chief Executive Pascal Soriot were shared by three of the investors partici…
-
General16 hours agoMan arrested after alleged carjackings, dramatic pursuit in Melbourne CBD
-
Noosa News19 hours agoHow to help kids prepare for music exams and competitions and manage performance anxiety
-
Noosa News22 hours agoOpera brilliance in Noosa | Noosa Today
-
Business18 hours agoBuy these ASX dividend shares for 4% to 6% yields